Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Diabetologia|May 29, 2004
Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteersR T de Jongh, A D H Clark, R G IJzerman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 28, 2015
Associations of vitamin D status and vitamin D-related polymorphisms with sex hormones in older menR Rafiq, N M van Schoor, E Sohl, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 22, 2016
[Paget's disease of bone: diagnosis and treatment]E M Winter, N A T Hamdy, R T de Jongh, et al.
International Journal of Cardiology|July 5, 2017
Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general populationT N Bonten, R de Mutsert, F R Rosendaal, et al.
Bone|June 20, 2018
Clinical utility of bone markers in various diseasesM C Vlot, M den Heijer, R T de Jongh, et al.
European Journal of Clinical Investigation|June 20, 2003
Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skinR G IJzerman, R T de Jongh, M A M Beijk, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 10, 2013
Prevalence of vitamin D deficiency and consequences for PTH reference valuesM M L Deckers, R T de Jongh, P T A M Lips, et al.
Calcified Tissue International|January 16, 2024
Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia PatientsA Bosman, N M Appelman-Dijkstra, A M Boot, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 11, 2012
Vitamin D status is associated with physical performance: the results of three independent cohortsE Sohl, R T de Jongh, A C Heijboer, et al.
Vaccine|September 29, 2023
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinationsA H A Lavell, A E Schramade, J J Sikkens, et al.
Pageof 3